XENON PHARMACEUTICALS INC

$XENE
Smart money positioned

14 of the Top-200 alpha managers hold $XENE as of the latest 13F snapshot.

13F holders
277
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

14 holders · Q1 2026

$XENE is held by 14 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 1.57%, with an average of 0.38% of portfolio. Largest holder: Fidelis Capital Partners, LLC at 1.57%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 277 · Source: 13F-HR
01
TB Capital Gestao de Recursos Ltda.
0.03% of portfolio
12,605,204 sh
02
Altarock Partners LP
3.31% of portfolio
5,777,777 sh
03
Litman Gregory Wealth Management LLC
0.04% of portfolio
5,349,454 sh
04
Wellington Management Group LLP
1.92% of portfolio
4,491,653 sh
05
Fernbridge Capital Management LP
0.91% of portfolio
4,405,312 sh
06
Thomas H Lee Partners LP
0.13% of portfolio
4,175,982 sh
07
Mill Road Capital Management LLC
0.09% of portfolio
3,600,117 sh
08
Axa S.a.
1,720,533 sh
09
Human Investing LLC
5.08% of portfolio
1,675,000 sh
10
Geneva Capital Management LLC
1.11% of portfolio
1,615,696 sh
See all 277 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $XENE in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $XENE in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:36 UTC.